Skip to content
Home/Companies/HealthTech/Sapio Sciences
Sapio Sciences

Sapio Sciences

HealthTech·USA·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Sapio Sciences?

Sapio Sciences is an American HealthTech company, currently owned by GHO Capital since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
GHO Capital
Investor
GHO Capital
GHO Capital III LP · 2021 · Buyout

Key facts

HQUSA
SectorHealthTech
Websitewww.sapiosciences.com

More from GHO Capital III LP

Other portfolio companies in the same fund.

Alcami Corporation
Alcami Corporation
Active
PharmaUS· 2022
Sanner
Sanner
Active
MedTechGermany· 2022
Biocare Medical
Biocare Medical
Exited 2026
MedTechUS· 2021
to Agilent Technologies
Clearview Healthcare Partners
Clearview Healthcare Partners
Active
Business ServicesUS· 2021
Envision Pharma
Active
HealthcareUK· 2021
Genesis Research
Genesis Research
Active
HealthTechUS· 2021

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Sapio Sciences?

Sapio Sciences is currently owned by GHO Capital, through GHO Capital III LP, since 2022.

When did GHO Capital acquire Sapio Sciences?

GHO Capital acquired Sapio Sciences in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue